All In Biotech

Free tool

FAERS Monitor: Simponi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125289 or its brand name (Simponi, Golimumab). Reports on generic versions are filed under their own applications.

Reports

82,613

Serious

63,267

77% of reports

Hospitalization

20,569

Death reported

6,620

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective20,904
  • rheumatoid arthritis14,421
  • pain13,603
  • fatigue11,495
  • off label use10,334
  • joint swelling9,990
  • arthralgia9,925
  • rash9,542
  • alopecia9,499
  • drug intolerance9,039
  • abdominal discomfort8,929
  • swelling8,729
  • systemic lupus erythematosus8,670
  • contraindicated product administered8,526
  • pemphigus8,418

Reports by year received

View as table
YearReports
20061
2009162
2010466
2011926
20121,390
20131,783
20141,502
20155,521
20165,121
20175,146
20186,113
20196,581
20209,069
20217,170
20226,970
20236,296
20247,865
20256,880
20263,651

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,971,546 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal8,418521.7502.91,432,661
contraindicated product administeredSignal8,52699.497.0597,453
systemic lupus erythematosusSignal8,67081.980.1524,874
rheumatoid arthritisSignal14,42136.936.3442,053
drug intoleranceSignal9,03926.225.6199,302
swellingSignal8,72926.125.5191,769
joint swellingSignal9,99022.922.4192,826
abdominal discomfortSignal8,92914.314.0105,038
alopeciaSignal9,49912.912.6100,063
arthralgiaSignal9,9256.26.143,114
painSignal13,6035.75.753,667
rashSignal9,5425.75.636,705
drug ineffectiveSignal20,9044.14.051,176
fatigueSignal11,4953.83.724,265
off label useSignal10,3343.03.014,477

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.